Dr. Berry-Kravis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1725 W Harrison St
Ste 710
Chicago, IL 60612Phone+1 312-942-3034
Education & Training
- University of ChicagoResidency, Neurology, 1987 - 1990
- University of ChicagoResidency, Pediatrics, 1985 - 1987
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1985
Certifications & Licensure
- IL State Medical License 1987 - 2026
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Clinical Trials
- Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome Start of enrollment: 2008 Nov 01
- Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001 Start of enrollment: 2009 Jan 01
- A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome Start of enrollment: 2014 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsFMR1 CGG Repeats and Stress Influence Self-Reported Cognitive Functioning in Mothers.Nell Maltman, Leann Smith DaWalt, Jinkuk Hong, Mei Wang Baker, Elizabeth M Berry-Kravis
American Journal on Intellectual and Developmental Disabilities. 2023-01-01 - 19 citationsSleep problems in fragile X syndrome: Cross-sectional analysis of a large clinic-based cohort.Dejan B Budimirovic, Dragana D Protic, Carol M Delahunty, Howard F Andrews, Tse-Hwei Choo
American Journal of Medical Genetics. Part A. 2022-04-01 - 34 citationsMavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents.Randi J Hagerman, Sébastien Jacquemont, Elizabeth Berry-Kravis, Vincent des Portes, Andrew C. Stanfield
Scientific Reports. 2018-11-19
Authored Content
- Volumetric Analysis of the Basal Ganglia and Cerebellar Structures in Patients with Phelan-McDermid SyndromeSeptember 2018
- Volumetric Analysis of the Basal Ganglia and Cerebellar Structures in Patients with Phelan-McDermid SyndromeSeptember 2018
- Long-Term Treatment of Niemann-Pick Type C1 Disease with Intrathecal 2-Hydroxypropyl-Β-cyclodextrinJanuary 2018
Press Mentions
- Experimental Drug Signals Hope for Fragile X SyndromeOctober 1st, 2024
- Investigational Drug for Fragile X Syndrome Improves CognitionSeptember 24th, 2024
- Rush Named Batten Disease Clinical Center of ExcellenceAugust 14th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: